Abstract
Objective
To evaluate the efficacy of the clinical pathway known as the best linkage for expeditious expert decision (BLEED) system that we newly developed for the effective management of postpartum bleeding.
Methods
This study was designed as a retrospective analysis. From January 2015 to May 2019, 155 patients who were treated for postpartum hemorrhage were included in our study. The non-BLEED group included 86 patients who admit with postpartum hemorrhage before the introduction of BLEED system, and the BLEED group included 69 patients who were applied with BLEED system. We compared the outcomes between two groups including duration of hospital stay and amount of transfusion.
Results
Duration of hospital stay was shorter in BLEED group than in non-BLEED group (4.0±1.9 vs. 4.7±2.7 days, P<0.05). Amount of red blood cell transfusion was less in BLEED group than in non-BLEED group (4.7±3.3 vs. 6.4±5.4 units, P<0.05). There were no difference in clinical characteristics, initial laboratory value, time to get a blood transfusion between the two groups. There were no difference between the two groups in terms of management techniques, such as uterotonics, intrauterine balloon tamponade, pelvic artery embolization and cesarean hysterectomy.
Figures and Tables
Table 1
Values are presented as mean±standard deviation or number (%).
Abbreviations: BLEED, best linkage for expeditious expert decision; LGA, large for gestational age; PPH, postpartum hemorrhage; Hb, hemoglobin; Hct, hematocrit; PLT, platelet; PT, prothrombin time; INR, international normalized ratio; PTT, partial thromboplastin time; FDP, fibrin degradation product.
*Use the decimal system.
References
1. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006; 367:1066–1074.
2. Dildy GA 3rd. Postpartum hemorrhage: new management options. Clin Obstet Gynecol. 2002; 45:330–344.
4. Pahlavan P, Nezhat C, Nezhat C. Hemorrhage in obstetrics andgynecology. Curr Opin Obstet Gynecol. 2001; 13:419–424.
5. Mason BA. Postpartum hemorrhage and arterial embolization. Curr Opin Obstet Gynecol. 1998; 10:475–479.
6. Wise A, Clark V. Challenges of major obstetric haemorrhage. Best Pract Res Clin Obstet Gynaecol. 2010; 24:353–365.
7. Cameron CA, Roberts CL, Bell J, Fischer W. Getting an evidence-based post-partum haemorrhage policy into practice. Aust N Z J Obstet Gynaecol. 2007; 47:169–175.
8. Deneux-Tharaux C, Dupont C, Colin C, Rabilloud M, Touzet S, Lansac J, et al. Multifaceted intervention to decrease the rate of severe postpartum haemorrhage: the PITHAGORE6 cluster-randomised controlled trial. BJOG. 2010; 117:1278–1287.
9. Cho HY, Na S, Kim MD, Park I, Kim HO, Kim YH, et al. Implementation of a multidisciplinary clinical pathway for the management of postpartum hemorrhage: a retrospective study. Int J Qual Health Care. 2015; 27:459–465.
10. Seo K, Park MI, Kim SY, Park JS, Han YJ. Changes of maternal mortality ratio and the causes of death in Korea during 1995-2000. Korean J Obstet Gynecol. 2004; 47:2345–2350.
11. Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum hemorrhage: United States, 1994-2006. Am J Obstet Gynecol. 2010; 202:353.e1–353.e16.
12. Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle MH, Ford JB, et al. Trends in postpartum hemorrhagein high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth. 2009; 9:55.
13. Kang CS, Park SY, Lee JY, Oh JY, Ju WD, Kim SK, et al. Applicable indications and effectiveness of the selective arterial embolization in the management of obstetrical hemorrhage. Korean J Obstet Gynecol. 2004; 47:51–59.